CMIC HOLDINGS Co.,Ltd. (E05292) Income statement

Market cap

P/E ratio

Symic Holdings supports pharmaceutical companies through the entire drug lifecycle with research, development, manufacturing, and sales services, while also providing digital healthcare solutions to medical facilities and communities.

Summary Financials Dividends History Workforce

Income statement Balance sheet Cash flow Other

	2010/09	2011/09	2012/09	2013/09	2014/09	2015/09	2016/09	2017/09	2018/09	2019/09	2020/09	2021/09	2022/09	2023/09
Revenue	35,861	43,555	50,303	50,934	52,836	55,904	62,039	65,282	69,869	74,373	76,098	85,788	108,461	104,701
Cost of revenue	-	-	-	38,792	41,948	44,816	48,941	51,044	54,976	58,261	61,451	68,061	82,203	79,999
Gross profit	-	-	-	12,142	10,887	11,087	13,097	14,237	14,892	16,112	14,646	17,727	26,258	24,702
Gross margin (%)	-	-	-
Operating expenses	-	-	-	7,985	8,120	9,676	9,733	10,340	10,570	11,706	12,041	12,806	14,412	14,434
Operating income	-	-	-	4,156	2,766	1,411	3,363	3,897	4,321	4,405	2,605	4,920	11,845	10,267
Income before tax	3,214	3,712	3,835	3,941	2,645	970	2,989	3,732	4,061	3,841	2,867	5,091	13,450	10,022
Provision for income taxes	-	-	-	2,242	1,267	1,797	1,577	1,596	2,187	1,785	792	2,397	2,994	4,585
Net income	1,786	1,811	2,241	1,753	1,174	-542	1,022	1,672	1,761	1,822	1,505	2,023	9,045	7,289
Earnings per share	2,032.36	100.73	123.25	97.36	65.26	-29.57	47	82.9	79.71	98.93	83.27	111.85	469.44	416.25